Evidence map›Paper›PMID 29770132›Full record

ArticleFrontiers in immunology2018

Differing Outcome of Experimental Autoimmune Encephalitis in Macrophage/Neutrophil- and T Cell-Specific gp130-Deficient Mice.

Kristian Holz, Marco Prinz, Stefanie M Brendecke, Alexandra Hölscher, Fengyuan Deng, Hans-Willi Mitrücker, Stefan Rose-John, Christoph Hölscher

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Recent Insights Into Targeting Interleukin-27 in Coronary Artery Disease.Journal of cardiovascular translational research · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. CD3Frontiers in immunology · 2021
    Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Kristian HolzDivision of Infection Immunology, Research Center Borstel, Borstel, Germany.
Marco PrinzInstitute of Neuropathology, Medical Faculty University of Freiburg, Freiburg, Germany.
Stefanie M BrendeckeInstitute of Neuropathology, Medical Faculty University of Freiburg, Freiburg, Germany.
Alexandra HölscherDivision of Infection Immunology, Research Center Borstel, Borstel, Germany.
Fengyuan DengDivision of Infection Immunology, Research Center Borstel, Borstel, Germany.
Hans-Willi MitrückerInstitute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Stefan Rose-JohnDepartment of Biochemistry, Christian-Albrechts-University, Kiel, Germany.
Christoph HölscherDivision of Infection Immunology, Research Center Borstel, Borstel, Germany.
Research Center Borstel - Leibniz Lung Center · DEUniversity of Freiburg · DEKiel University · DEUniversity Medical Center Hamburg-Eppendorf · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

gp130 cytokines are differentially involved in regulating the T helper (H) 17-driven pathogenesis of experimental autoimmune encephalomyelitis (EAE), the animal model of human multiple sclerosis. Interleukin (IL)-6 directly promotes the development of TH17 cells through the gp130/IL-6R complex. By contrast, IL-27 has been shown to suppress a TH17 immune response by gp130/IL-27R-alpha (α) receptor ligation. The IL-27-dependent regulation of a TH17 development could be mediated on the level of CD4 T cells. However, because IL-27 also suppresses the secretion of the TH17-driving cytokines IL-6 and IL-12/23p40 in accessory cells, TH17 immune responses may also be controlled by IL-27 on the level of macrophages and/or neutrophils. To analyze these opposing effects of gp130 engagement on the pathogenesis of EAE, we immunized CD4

Indexed as

AnimalsCell DifferentiationCentral Nervous SystemCytokine Receptor gp130CytokinesDisease Models, AnimalDisease ProgressionEncephalomyelitis, Autoimmune, ExperimentalInflammationMacrophagesMiceMyelin-Oligodendrocyte GlycoproteinNeutrophilsTh17 CellsTh1 CellsCytokine Receptor gp130CytokinesMyelin-Oligodendrocyte Glycoproteinexperimental autoimmune encephalomyelitis/multiple sclerosisgp130 cytokineinflammation mediatorsinterleukin-27interleukin-6

Identifiers

PMID29770132
PMCPMC5940746
OpenAlexW2797056577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.